Publication | Closed Access

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Idiopathic Pulmonary FibrosisPharmacologyPulmonary PharmacologyPulmonary FibrosisPulmonary MedicineMedicinePirfenidone Combination TherapyPulmonary Disease